In partnership with
Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.
A lot of people still treat cannabis like a lifestyle story. Courts, agencies, and statehouses treat it like a set of consequences. Today’s edition tracks the places where that reality shows up: federal judges deciding which deals they will enforce, DOJ shaping the way cannabis use gets described in a gun rights case, and Virginia moving from long delay toward a real adult-use build. The hemp beverage lane keeps getting more organized as wholesalers follow retailer demand, while Massachusetts reminds everyone that a strong market can outlive a messy regulator for only so long.
Today’s edition is supported by Fisher Investments and Masterworks. To sponsor Policy, Decoded and reach the executives, investors, and policymakers who read this briefing, reply to this email and we will send details.
⚖️ Federal Lines Get Sharper
🏛️ States Build Or Stall
🚚 Distribution Picks Winners
Results outlive personalities.
What Will Your Retirement Look Like?
Planning for retirement raises many questions. Have you considered how much it will cost, and how you’ll generate the income you’ll need to pay for it? For many, these questions can feel overwhelming, but answering them is a crucial step forward for a comfortable future.
Start by understanding your goals, estimating your expenses and identifying potential income streams. The Definitive Guide to Retirement Income can help you navigate these essential questions. If you have $1,000,000 or more saved for retirement, download your free guide today to learn how to build a clear and effective retirement income plan. Discover ways to align your portfolio with your long-term goals, so you can reach the future you deserve.
Fast-moving headlines, flagged for what matters.
The Third Circuit signaled that some cannabis contracts can become unenforceable the moment they land in federal court, and it did so without turning itself into a cannabis policy forum. In Apical Biotek v. Maitri Holdings, the panel told the trial court to examine whether the agreement required conduct illegal under federal drug law, even if the remedy sought is money damages. That posture fits the broader trend, with federal courts hesitant to bless cannabis as doctrine while federal illegality supplies a clean off ramp. The litigation playbook is obvious: remove to federal court, force an illegality inquiry, and squeeze plaintiffs into dismissal or discounted settlement. Operators and investors should treat enforceability and venue as diligence items that belong in dispute clauses and deal structure when equity or management rights touch plant activity. (Regulatory Oversight)
DOJ is defending the federal ban on gun possession by unlawful users of controlled substances by leaning on historical limits tied to dangerousness, including disarmament of the mentally ill. The legal strategy is to fit the ban into the post-Bruen framework without relying on modern policy arguments about drugs and firearms. That framing carries spillover risk for cannabis, because it invites courts to treat marijuana use as a marker of incapacity or heightened danger even in legal states. The outcome matters beyond the gun context, since it shapes how federal law describes cannabis consumers when constitutional rights are at stake. Federal legalization remains the clean solution, and litigation forces courts to pick categories that often age poorly. (Law360)
Virginia lawmakers moved sales, resentencing relief, and hospital access forward at crossover, and the biggest story is momentum in a state that has been stuck for years. The House and Senate bills carry different start dates, tax structures, and different visions for the regulator, which makes institutional design the real negotiation. The resentencing and hospital measures help the political framing, yet implementation capacity will decide whether the market is stable or chaotic on arrival. Gov. Abigail Spanberger’s support changes the center of gravity, because the legislature can no longer treat a veto as the default endpoint. Virginia now faces the hard work of building a market that functions, not simply passing a bill. (Marijuana Moment)
A University at Buffalo study reported that cannabis users who switched to cannabis-infused beverages cut their weekly alcohol intake roughly in half and reported fewer binge-drinking episodes. Nearly two-thirds said they reduced or stopped drinking alcohol after starting cannabis drinks, with researchers pointing to the familiar social ritual of holding a canned beverage as part of the substitution effect. The evidence base is still early and self-reported, yet it gives lawmakers and wholesalers a new talking point that will show up in every hemp THC and adult-use beverage debate this year. The policy pressure point is labeling and dosing, because harm reduction arguments collapse fast when products are inconsistent or overpowered. Expect regulators to demand clearer serving sizes and tighter guardrails, and expect the beverage lane to keep pushing the public health frame as a way to earn legitimacy. (ScienceDaily)
New York regulators sided with a licensed operator challenging a town zoning approach that functions like a quiet opt out after the opt out window closed. The dispute turns on local permitting requirements and added conditions the state views as preempted because they frustrate licensed operations. This case draws the practical line between legitimate time, place, and manner zoning and rules engineered to delay or veto through process. Operators should treat municipal process as litigation risk and build a record early, since slow-walk tactics rarely announce themselves. A clear outcome would reduce uncertainty and push more towns toward workable guardrails instead of procedural trench warfare. (Law360)
Alcohol wholesalers are leaning into hemp-derived THC beverages for the simplest reason in the business: retailers want what customers buy. The closer you get to the customer, the more acceptance shows up, and distribution follows demand faster than politics. That explains why the trade is now talking to Congress, because wholesalers prefer rules that let them move compliant product through familiar channels with familiar training and accountability. It is also a positioning move, since whoever sets dosing norms, package expectations, and retailer standards gets durable influence over the category. The category will be defined by scaled compliance and retailer comfort, and wholesalers are built for that job. (Shanken News Daily)
The Virgin Islands ordered an immediate halt to specified intoxicating hemp products under Act No. 9072, and it lands as enforcement plus market preparation. The order targets THCA and Delta-6, Delta-8, and Delta-10 THC products unless the seller holds licensure through the Office of Cannabis Regulation, with escalating penalties for repeat violations. That clears shelf space and narrows competition as the territory builds an adult-use system, which is a familiar protectionist move in new markets. The risk is predictable too, since shutdown orders without an accessible lawful pathway can push demand into informal channels. If regulators want durable compliance, they need a clear bridge from current retail behavior into the licensed system. (The Virgin Islands Consortium)
Missouri is debating intoxicating hemp with an open question in the background: who gets the keys, the cannabis regulator or the convenience-store lane. Proposals would steer hemp-derived intoxicants toward a marijuana-style regulatory framework, tightening consumer protections and reshaping the competitive map quickly. The enforcement hinge matters most, because a hard cutoff without capacity creates a gray market that simply relocates. This becomes a delegation issue fast if businesses start calling members of Congress about federal deadlines and preemption risk. Missouri can land this cleanly if it builds a transition path that preserves age-gated compliance and avoids punting demand into the shadows. (Columbia Missourian)
Massachusetts cleared $9 billion in adult-use sales, and the snowstorm spike shows the market still has predictable demand and reliable access. That stability reflects the original foundation, even as the Commission now projects dysfunction that drags attention away from the work. Price compression and margin pressure remain real, yet the market stayed durable for years because the rules and systems held and the industry learned how to operate inside them. The risk now is sustained governance distraction, since uncertainty eventually gets priced into capital, expansion, and compliance posture. Massachusetts does not need reinvention, it needs the work to be bigger than the people doing it.(Marijuana Moment)
Kentucky’s medical program is moving from cards to storefronts, and advocates are already warning the state about affordability and geographic access. Early dispensary openings show demand, and they also expose the risk of tight supply and thin competition that can price patients out. Program legitimacy depends on whether a patient on a fixed income can buy what their clinician authorized without driving hours or rationing care. This is where design stops being theoretical, because licensing cadence, product availability, and competition shape real health outcomes. Kentucky can protect its credibility by treating pricing and access as public health obligations, not retail afterthoughts. (WDRB)
Pittsburgh City Council urged Gov. Josh Shapiro and lawmakers to legalize adult use, and the argument is practical as much as moral. Pennsylvania residents already buy legally in surrounding states, which means the Commonwealth exports commerce, taxes, and consumer protections every weekend. The resolution will not move votes by itself, yet it sharpens the frame that matters in Harrisburg: legalization as competitiveness and budget reality. Shapiro’s revenue posture keeps the issue in the fiscal lane, where details on market structure and enforcement will decide whether legalization is functional. Border states will keep collecting Pennsylvania money until Pennsylvania decides it wants the job. (TribLive)
Hawaii senators are advancing adult-use bills even as key House leaders have signaled that full legalization is dead for the 2026 session. One proposal would create a Cannabis and Hemp Office inside the Department of Commerce and Consumer Affairs, yet the trigger turns on future federal law or a constitutional change, which delays the hard choices. Another bill strips out commercial sales, keeping the issue moving while lowering political risk for members who want reform headlines without implementation responsibility. Committees also discussed narrower fixes, including hemp-derived cannabinoid policy and a one-time medical purchase option for patients waiting on registration. The throughline is capacity and credibility: Hawaii keeps flirting with legalization without building the coalition or the administrative plan that makes implementation feel safe. (Marijuana Moment)
An Arizona senator wants to treat excessive marijuana odor as a criminal nuisance, and it reads like NIMBY frustration packaged as public health. The bill presumes excessive odor is injurious and offensive, shifting the burden toward the homeowner to rebut it, while never defining what excessive means. That is an enforcement recipe built on subjectivity, which invites uneven outcomes and plenty of selective complaints. A companion measure would send the same policy to voters, anticipating limits on legislative edits to voter-approved legalization. If it advances, landlords and multi-unit operators will feel pressure first, and local government will get a new lever to police lifestyle disputes through criminal law. (Capitol Media Services)
The BRASS KNUCKLES trademark dispute tied to Xzibit is a reminder that cannabis branding depends on clean ownership and clean assignments. When marital property rules and layered entities collide, courts focus on authority and chain of title, not brand heat. The operational risk is immediate: licensing leverage can weaken, partners can pause, and retailers can back away when ownership looks uncertain. Even sophisticated teams miss these traps when deal momentum outruns documentation. Audit chain of title like you audit inventory, and do it before the dispute shows up. (JD Supra)
A UK Biobank analysis linked moderate lifetime cannabis use with better cognitive performance and larger volumes in certain brain regions, and the headline will outrun what the data can support. Observational work cannot reliably measure potency, product type, and patterns of use, which limits what clinicians and policymakers can responsibly infer. The study also found reduced volume in another region tied to memory and emotion processing, which should curb any temptation to treat this as a health claim. Older adults deserve candor, since some people use cannabis without obvious decline and medicine still lacks tight guidance grounded in controlled trials. The responsible posture is curiosity and restraint, with zero tolerance for marketing that tries to turn correlation into endorsement. (Pain News Network)
Wall Street Just Named the Most Crowded Trades of 2026
AI stocks. Metals. Crypto.
Surprise, surprise; gold crashed 16%. Silver plunged 34%. Bitcoin dropped to 1 year lows.
All supposedly "uncorrelated" assets moving in lockstep largely because of overleveraged margin.
JPM strategists warn that the same leverage is still a risk.
Those markets may be recovering now, but cascading liquidations could trigger quickly across several asset classes simultaneously.
So much for diversifying away risk, right?
But get this–
70,819 everyday investors have allocated $1.3 billion fractionally across 500+ exclusive investments.
Not real estate or PE… Blue-chip art. Sounds crazy, right?
Now it’s easy to invest in art featuring legends like Banksy, Basquiat, and Picasso, thanks to Masterworks.
They do the heavy lifting from acquisition to sale, so you can diversify with the strategy typically limited to the ultra-wealthy.
(Past sales delivered net returns like 14.6%, 17.6%, and 17.8% on works held longer than a year.)*
*Investing involves risk. Past performance is not indicative of future returns. Important Reg A disclosures: masterworks.com/cd
From the hearing room to the comment section — we’re watching it all.
🍺 Two former Lagunitas executives joined Cornbread Hemp’s advisory board, bringing distributor and retail muscle from a craft beer playbook that scaled into a billion-dollar exit. Expect more of this, since hemp beverage growth is pulling in people who know how to win shelf space, price a product, and keep accounts loyal. (mg Magazine)
💍 Illinois retailer Ivy Hall plans to host what it calls the first cannabis wedding and vow renewal celebration, branded “Weed Love to Marry You,” positioning retail space as event venue and cultural stage. The move underscores how adult-use markets are normalizing cannabis in milestone moments, even as operators still navigate strict advertising and on-site consumption rules. (PR Newswire)
💳 South Dakota health officials plan to move medical marijuana registry cards to a digital format, a shift that could speed verification for patients and law enforcement while reducing replacement hassles and administrative drag. It also tees up the next policy argument, since digital credentials raise questions about privacy, interoperability with ID checks, and what happens when connectivity fails at point of sale. (South Dakota Searchlight)
✈️ Three British Airways cabin crew members reportedly ate gummy candies gifted by a passenger after a London to Los Angeles flight and ended up hospitalized once they realized the package contained high dose THC edibles. The episode will harden airline and airport zero tolerance posture and it reinforces a basic consumer truth for regulated markets: dosing and packaging clarity matter most when the product leaves the dispensary bubble and collides with federal transport rules. (TravelPulse)